 |
|---|
CardioComm Solutions Inc. to Unveil New Enterprise Version of GlobalCardioT and New Release of GEMST at the Heart Rhythm Society Annual Meeting
|
VICTORIA , B.C., May 02, 2005 - CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm"), is pleased to report that it will be attending and exhibiting (Booth # 1918) at the Annual Heart Rhythm Society (HRS) 2005 which runs May 4 -7 in New Orleans , LA.
CardioComm will be proudly showcasing its entire family of cardiac software technology with specific focus being given to the unveiling of the Company's newest offering of GlobalCardio Enterprise and the latest release of GEMS.
The Company is introducing the GlobalCardio Enterprise Version , a competitively un matched product that brings the one time exclusively centrally hosted application, to the customer's own environment. The industry will recognize this as a fully installable, customer hosted, Web-based application. It introduces a new dynamic in the field of pacemaker and ICD follow up software systems. This application will enable customers to deploy their own remotely accessible application for patient follow up and report viewing. GlobalCardio Enterprise offers all of the security and user audit tracking found in the current CardioComm ASP product, but may now introduces the option to be purchased outright and be separately hosted. CardioComm can still deliver updates over the web, improving access to new features and product updates. GlobalCardio Enterprise is the latest complement to CardioComm's growing list of product offerings designed to provide our customers with the most technically advanced, flexible, and economically suitable solutions.
In terms of GEMS, the Company is releasing the GEMS Version 3 for Pacemaker and ICD Follow Up . Highlights of this version include:
The products will be on display at HRS 2005 in New Orleans , Booth #1918.
About CardioComm Solutions Inc:
CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMST) and GlobalCardioT. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.
|
On behalf of the Board of Directors of CardioComm Solutions Inc.:
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin |
